GBA1 and Parkinson disease: However, when the hyperechogenic area of the substantia nigra, a prodromal PD marker, was measured in a large cohort of GBA mutation carriers (n = 71) and patients with GD (n = 145) it did not correlate with levels of GlcSph [31].